Radioactive 'Smart Bomb' targets Hard-to-Treat tumors
Disease control
Ongoing
This phase 2 study tests a drug called 212Pb-DOTAMTATE, which delivers radiation directly to neuroendocrine tumor cells. It includes 69 adults whose tumors have grown despite standard treatments. The goal is to see if the drug shrinks tumors and to check for side effects.
Phase: PHASE2 • Sponsor: Orano Med LLC • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC